Evidence map›Paper›PMID 39623740›Full record

ArticleBiotechnology journal2024

Autophagy and Akt-Stimulated Cellular Proliferation Synergistically Improve Antibody Production in CHO Cells.

Leran Mao, Sarah Michelle Sonbati, James W Schneider, Anne S Robinson

Abstract read
In one paragraph

Article in Biotechnology journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Leran MaoDepartment of Chemical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania, USA.ORCID https://orcid.org/0000-0001-9106-9836
Sarah Michelle SonbatiDepartment of Chemical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania, USA.
James W SchneiderDepartment of Chemical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania, USA.
Anne S RobinsonDepartment of Chemical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania, USA.ORCID https://orcid.org/0000-0001-7235-1481

Funding

Project Award Agreement from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) 70NANB21H06TechnologyU.S. Department of Commerce, National Institute of Standards and
6 · The paper itself

Abstract

Over the past decade, engineered producer cell lines have led 10-fold increases in antibody yield, based on an improved understanding of the cellular machinery influencing cell health and protein production. With prospects for further production improvements, increased antibody production would enable a significant cost reduction for life-saving therapies. In this study, we strategized methods to increase cell viability and the resulting cell culture duration to improve production lifetimes. By overexpressing the cell surface adenosine A

Indexed as

AutophagyCell ProliferationCricetulusProto-Oncogene Proteins c-aktAnimalsAntibody FormationBeclin-1Cell SurvivalCHO CellsCricetinaeReceptor, Adenosine A2ABeclin-1Proto-Oncogene Proteins c-aktReceptor, Adenosine A2Aantibodiescell culturecellular engineeringCHO cells

Identifiers

PMID39623740
PMCPMC11612535

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.